Computer-Aided Directed Evolution Generates Novel AAV Variants with High Transduction Efficiency

Viruses. 2023 Mar 26;15(4):848. doi: 10.3390/v15040848.

Abstract

Adeno-associated viruses (AAVs) have become safe and effective tools for therapeutic in vivo gene drug delivery. Among many AAV serotypes, AAV2 is the most well-characterized. Although many studies have been carried out on the engineering of the capsid VR-VIII region, few attempts have been made in the VR-IV region. Here, we targeted amino acid positions 442-469 of the VR-IV region and established an engineering paradigm of computer-aided directed evolution, based on training samples from previous datasets, to obtain a viral vector library with high diversity (~95,089). We further examined two variants selected from the library. The transduction efficiency of these two novel AAV variants, AAV2.A1 and AAV2.A2, in the central nervous system was 10-15 times higher than that of AAV2. This finding provides new vehicles for delivering gene drugs to the brain.

Keywords: Cap gene library; adeno-associated virus; computer-aided design; directed evolution; transduction efficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Capsid Proteins* / metabolism
  • Capsid* / metabolism
  • Dependovirus / physiology
  • Gene Library
  • Genetic Therapy
  • Genetic Vectors / genetics
  • Transduction, Genetic

Substances

  • Capsid Proteins

Grants and funding

This work was supported by the STI2030-Major Projects (2021ZD0201003), the National Natural Science Foundation of China (31830035, 31771156, 21921004, 82151309), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB32030200), the Shenzhen Key Laboratory of Viral Vectors for Biomedicine (ZDSYS20200811142401005), and the Key Laboratory of Quality Control Technology for Virus-Based Therapeutics, Guangdong Provincial Medical Products Administration (2022ZDZ13).